Riskpilot← Back to searchSign inGet full accessMERLIN MEDTECH AS
ASActiveOrg 921699891Høgåsvegen 99, 3684 NotoddenManufacture of medical and dental instruments and supplies · NACE 3250Est. 20182 employees
Revenue 2023
NOK 278K
EBITDA margin
-614.3%
+1% vs 2022
Equity ratio
3.7%
Financial strength
Net profit 2023
NOK -1,7M
-14% vs 2022
| Revenue | NOK 278K | — |
| EBITDA | NOK -1,7M | +1% |
| Net profit | NOK -1,7M | -14% |
| Total assets | NOK 11,4M | +58% |
| Equity | NOK 427K | -79% |
| Employees | 2 | — |
Legal name
MERLIN MEDTECH AS
Org number
921699891
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
12. november 2018
Share capital
NOK 73 641
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Utvikle og selge løsninger innen for medisinsk teknisk sektor, heruder også eierskap i andre relaterte selskaper.
Address
Høgåsvegen 99, 3684 Notodden
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue | 50 | 86 | 0 | 516 | 0 | 278 |
| Staff expenses | −0 | −0 | −126 | −7 | −306 | −996 |
| EBITDA | 44 | −850 | −1 015 | −502 | −1 719 | −1 708 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 44 | −850 | −1 015 | −502 | −1 719 | −1 708 |
| Net financials | 997 | 1 273 | −1 | 1 884 | −29 | −511 |
| Profit before tax | 1 041 | 422 | −1 016 | 1 381 | −1 748 | −2 220 |
| Tax | 10 | −187 | −224 | −113 | −288 | −558 |
| Net profit | 1 031 | 610 | −793 | 1 494 | −1 460 | −1 661 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Total assets | 1 074 | 1 816 | 2 636 | 4 798 | 7 240 | 11 428 |
| Equity | 1 061 | 1 677 | 2 040 | 3 536 | 2 076 | 427 |
| Long-term debt | 0 | 0 | 0 | 0 | 200 | 1 200 |
| Short-term debt | 13 | 140 | 596 | 1 262 | 4 964 | 9 800 |
| Total debt | 13 | 140 | 596 | 1 262 | 5 164 | 11 000 |
EBITDA margin
-614.3%
This company
15.8%
Market median
-3988% vs market
20182023
Equity ratio
3.7%
This company
38.2%
Market median
-90% vs market
20182023
Return on equity
-388.9%
This company
18.4%
Market median
-2214% vs market
20182023
Net profit margin
-597.3%
This company
8.1%
Market median
-7474% vs market
20182023
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20182023
Debt / equity
25.76×
This company
0.62×
Market median
-4055% vs market
20182023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-09-19 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RE Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bulldozer Holding As | Company | 28.8% | 28.8% | 2023 |
Merlin Holding As | Company | 20.2% | 20.2% | 2023 |
| Individual | 12.2% | 12.2% | 2023 | |
Vmr As | Company | 9.9% | 9.9% | 2023 |
| Individual | 5.0% | 5.0% | 2023 | |
Hotra As | Company | 3.0% | 3.0% | 2023 |
Xplorico Communities As | Company | 3.0% | 3.0% | 2023 |
| Individual | 2.9% | 2.9% | 2023 | |
| Individual | 2.6% | 2.6% | 2023 | |
Grøten Invest As | Company | 2.2% | 2.2% | 2023 |
| Individual | 2.0% | 2.0% | 2023 | |
Merlin Medtech As | Company | 1.8% | 1.8% | 2023 |
| Individual | 1.6% | 1.6% | 2022 | |
| Individual | 1.5% | 1.5% | 2023 | |
| Individual | 1.5% | 1.5% | 2023 | |
Magne Lyngner As | Company | 1.4% | 1.4% | 2023 |
| Individual | 1.3% | 1.3% | 2023 | |
| Individual | 1.3% | 1.3% | 2023 | |
Feltskjær As | Company | 1.1% | 1.1% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MERLIN MEDTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rune Elvrum Akselsen | Chief Executive Officer | 0 companies |
| Simen Andreas Munter | Board of Directors | 0 companies |
| Christian Alexander Holm Glad | Board of Directors | 0 companies |
| Thorleif Johan Holm Glad | Board of Directors | 0 companies |
| Kjell Holen | Board of Directors | 0 companies |
| Hjørdis Saastad | Board of Directors | 0 companies |
| Håkon Christian Vikse Grøthe | Board of Directors | 0 companies |
| Ørjan Rolness | Chairman | 0 companies |